Adaptability and Persistence of the Emerging Pathogen Bordetella petrii

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Zelazny, Adrian M ^a,b   Ding, Li ^a   Goldberg, Joanna B ^c   Mijares, Lilia A ^b   Conlan, Sean ^d   Conville, Patricia S ^b   Stock, Frida ^b   Ballentine, Samuel J ^a   Olivier, Kenneth N ^a   Sampaio, Elizabeth P ^a,e   Murray, Patrick R ^b   Holland, Steven M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIGEN; ANTIMYCOBACTERIAL AGENT; AZTREONAM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CLOFAZIMINE; COTRIMOXAZOLE; GENOMIC DNA; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LIPOPOLYSACCHARIDE O ANTIGEN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; RIFAMPICIN; TIMENTIN; TOBRAMYCIN; UNCLASSIFIED DRUG; VORICONAZOLE;

ADAPTATION; ADAPTIVE IMMUNITY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; ATYPICAL MYCOBACTERIOSIS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BORDETELLA; BORDETELLA PETRII; BORDETELLOSIS; BRONCHIECTASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COUGHING; DYSPNEA; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LUNG BIOPSY; LUNG INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR RECOGNITION; MOUSE; MYCOBACTERIUM INTRACELLULARE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PNEUMOCYSTIS JIROVECI; SEQUENCE ANALYSIS; SPUTUM CULTURE; STRAIN DIFFERENCE; WHEEZING;

ADAPTATION, PHYSIOLOGICAL; ADAPTIVE IMMUNITY; ANIMALS; ANTIBODIES, BACTERIAL; BORDETELLA; FEMALE; HUMANS; IMMUNE EVASION; IMMUNIZATION; LUNG DISEASES; MICE; MIDDLE AGED; MUTATION; O ANTIGENS; SEQUENCE ANALYSIS;

BACTERIA (MICROORGANISMS); BORDETELLA PETRII; MUS;

EID: 84878635033     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065102     Document Type: Article

References (30)

1. Mattoo S, Cherry JD, (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18: 326-382.
2. Shepard CW, Daneshvar MI, Kaiser RM, Ashford DA, Lonsway D, et al. (2004) Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients. Clin Infect Dis 38: 799-804.
3. Tang YW, Hopkins MK, Kolbert CP, Hartley PA, Severance PJ, et al. (1998) Bordetella holmesii-like organisms associated with septicemia, endocarditis, and respiratory failure. Clin Infect Dis 26: 389-392.
4. Vandamme P, Heyndrickx M, Vancanneyt M, Hoste B, De Vos P, et al. (1996) Bordetella trematum sp. nov., isolated from wounds and ear infections in humans, and reassessment of Alcaligenes denitrificans Ruger and Tan 1983. Int J Syst Bacteriol 46: 849-858.
5. Ko KS, Peck KR, Oh WS, Lee NY, Lee JH, et al. (2005) New species of Bordetella, Bordetella ansorpii sp. nov., isolated from the purulent exudate of an epidermal cyst. J Clin Microbiol 43: 2516-2519.
6. Fry NK, Duncan J, Malnick H, Warner M, Smith AJ, et al. (2005) Bordetella petrii clinical isolate. Emerg Infect Dis 11: 1131-1133.
7. Weiss AA, Falkow S, (1984) Genetic analysis of phase change in Bordetella pertussis. Infect Immun 43: 263-269.
8. Preston A, Allen AG, Cadisch J, Thomas R, Stevens K, et al. (1999) Genetic basis for lipopolysaccharide O-antigen biosynthesis in bordetellae. Infect Immun 67: 3763-3767.
9. von Wintzingerode F, Schattke A, Siddiqui RA, Rosick U, Gobel UB, et al. (2001) Bordetella petrii sp. nov., isolated from an anaerobic bioreactor, and emended description of the genus Bordetella. Int J Syst Evol Microbiol 51: 1257-1265.
10. Stark D, Riley LA, Harkness J, Marriott D, (2007) Bordetella petrii from a clinical sample in Australia: isolation and molecular identification. J Med Microbiol 56: 435-437.
11. Le Coustumier A, Njamkepo E, Cattoir V, Guillot S, Guiso N, (2011) Bordetella petrii Infection with Long-lasting Persistence in Human. Emerg Infect Dis 17: 612-618.
12. Spilker T, Liwienski AA, LiPuma JJ, (2008) Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis. Clin Microbiol Infect 14: 504-506.
13. Moissenet D, Bingen E, Arlet G, Vu-Thien H, (2005) [Use of 16S rRNA gene sequencing for identification of "Pseudomonas-like" isolates from sputum of patients with cystic fibrosis]. Pathol Biol (Paris) 53: 500-502.
14. Gross R, Guzman CA, Sebaihia M, dos Santos VA, Pieper DH, et al. (2008) The missing link: Bordetella petrii is endowed with both the metabolic versatility of environmental bacteria and virulence traits of pathogenic Bordetellae. BMC Genomics 9: 449.
15. Lee MS, Lee YS, Chiou CS, (2006) The suitable restriction enzymes for pulsed-field gel electrophoresis analysis of Bordetella pertussis. Diagn Microbiol Infect Dis 56: 217-219.
16. Zelazny AM, Ding L, Elloumi HZ, Brinster LR, Benedetti F, et al. (2009) Virulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease. Infect Immun 77: 4337-4344.
17. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, et al. (2008) The RAST Server: rapid annotations using subsystems technology. BMC Genomics 9: 75.
18. Darling AC, Mau B, Blattner FR, Perna NT, (2004) Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res 14: 1394-1403.
19. CLSI (2010) Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
20. Lechner M, Schmitt K, Bauer S, Hot D, Hubans C, et al. (2009) Genomic island excisions in Bordetella petrii. BMC Microbiol 9: 141.
21. Andersson DI, Hughes D, (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8: 260-271.
22. Kirimanjeswara GS, Mann PB, Harvill ET, (2003) Role of antibodies in immunity to Bordetella infections. Infect Immun 71: 1719-1724.
23. Zhang X, Goebel EM, Rodriguez ME, Preston A, Harvill ET, (2009) The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis. Infect Immun 77: 5050-5058.
24. MacArthur I, Mann PB, Harvill ET, Preston A, (2007) IEIIS Meeting minireview: Bordetella evolution: lipid A and Toll-like receptor 4. J Endotoxin Res 13: 243-247.
25. Goebel EM, Wolfe DN, Elder K, Stibitz S, Harvill ET, (2008) O antigen protects Bordetella parapertussis from complement. Infect Immun 76: 1774-1780.
26. Burns VC, Pishko EJ, Preston A, Maskell DJ, Harvill ET, (2003) Role of Bordetella O antigen in respiratory tract infection. Infect Immun 71: 86-94.
27. Mooi FR, Bik EM, (1997) The evolution of epidemic Vibrio cholerae strains. Trends Microbiol 5: 161-165.
28. Iguchi A, Ooka T, Ogura Y, Asadulghani, Nakayama K, et al. (2008) Genomic comparison of the O-antigen biosynthesis gene clusters of Escherichia coli O55 strains belonging to three distinct lineages. Microbiology 154: 559-570.
29. Cunneen MM, Reeves PR, (2007) The Yersinia kristensenii O11 O-antigen gene cluster was acquired by lateral gene transfer and incorporated at a novel chromosomal locus. Mol Biol Evol 24: 1355-1365.
30. Buboltz AM, Nicholson TL, Karanikas AT, Preston A, Harvill ET, (2009) Evidence for horizontal gene transfer of two antigenically distinct O antigens in Bordetella bronchiseptica. Infect Immun 77: 3249-3257.